CA 19-9 lacks the sensitivity for detecting early pancreatic cancer and
is elevated in only 50% of pancreatic adenocarcinomas less than 3 cm in size.
Poorly-differentiated pancreatic cancer also appears to produce less CA 19-9 than moderately- or well-differentiated cancers.